Are drugs designed to work best for all patients?
Are randomised controlled trials achieving the results we need for patients? In the latest instalment of ERS Vision, Professor Elisabeth Bel leads a discussion on the relevance of real-life evidence and whether it can enhance existing guidelines.
The documentary considers how we can ask the right questions to provide the right solutions for each individual patient. Leading experts consider the value of this type of research, along with the issues surrounding quality standards, costs and how it can be effectively designed and applied.
European Respiratory Society: Should we be testing new drugs in the ‘real’ world where some patients smoke, are obese and have other comorbidities?
Share this post
Latest News posts
Margaret Griffiths
January 29, 2019
Man dies after inhaling fungal spores from garden compost
January 29, 2019
MagStar
January 29, 2019
M. Scott Johansen
January 29, 2019
Lisa McNeil
January 29, 2019
Kimberley Wendzel
January 29, 2019
Kay A.
January 29, 2019
John Bradley
January 29, 2019
Joan Becker – Xolair
January 29, 2019
The day I got told I am going to die
January 29, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video